Navigation Links
Hypertension Vaccine CYT006-AngQb Achieves Strong Blood Pressure,Reduction During Important Early Morning Period When Most Adverse,Cardiovascular Events Occur

on, which
is a counter-reaction of the body potentially decreasing the efficacy of current drug therapy1. In contrast to small molecule inhibitors, which display large variations in serum drug levels throughout the day, the vaccine-induced anti-angiotensin II antibodies were found to decline with a half-life of about 4 months. This may lead to a practically continuous inhibition of angiotensin II for weeks, which may in part account for the minor reactive rise observed in plasma renin concentration, and to the potent effect of the vaccine in early morning hours, as is further explained in the quote of Dr. Müller below.

A further important finding of the study is the dependence of efficacy on both the dose of the vaccine and the levels of induced anti-angiotensin II antibodies. Two doses of the vaccine, 100 ?g and 300 ?g, were tested in the trial. The induced anti-angiotensin antibody levels were significantly higher at the 300 ?g than at the 100 ?g dose (p=0.0098). Accordingly, blood pressure reduction was much larger and only significant at the 300 ?g dose (p=0.0498). Efficacy was thus driven by a longlasting, although reversible antibody response. Dr. Philipp Müller, EVP Clinical Development at Cytos Biotechnology comments on the study results:

“These data highlight a very important new aspect of the vaccine CYT006-AngQb, namely its exceptionally good control of the early morning blood pressure. So far, inhibition of the reninangiotensin system has been studied clinically only with small molecule inhibitors, which all produce a daily pattern of peaks and troughs in drug levels. Here, a trough in drug levels coincides with a natural rise of the blood pressure in early morning hours. The combination of these effects may lead to insufficient control of the early morning blood pressure surge. An intervention with a different pharmacokinetic profile like the vaccine approach, which avoids daily peaks and troughs in drug l
'"/>




Page: 1 2 3 4 5 6 7 8 9

Related medicine technology :

1. Speedel Reports Successful SPP635 Phase IIa Trial in Hypertension
2. Prexige Study Shows Significantly Less Impact on Blood Pressure Than Ibuprofen in Osteoarthritis Patients with Controlled Hypertension
3. Lumiracoxib Study Showed Significantly Less Impact on Blood Pressure Than Ibuprofen in Osteoarthritis Patients with Controlled Hypertension
4. Amlodipine and Olmesartan Study Results Released;Late Breaker Presented at American Society of Hypertension Twenty-Second Annual Scientific Meeting (ASH 2007)
5. Gilead Announces Presentation of Long-Term Data for Ambrisentan, a Potential Treatment for Patients With Pulmonary Arterial Hypertension
6. Hypertension Education Foundation Survey Results Announced At American Society For Hypertension Annual Meeting Suggests Improved Control Of High Blood Pressure, But Misconceptions Still Exist
7. New Data Highlights Potential of SPP100 (Tekturna) as Gold Standard Therapy in Treatment of Hypertension
8. Amlodipine and Olmesartan Study Results Released; Late Breaker Presented at American Society of Hypertension Twenty-Second Annual Scientific Meeting (ASH 2007)
9. King Pharmaceuticals Announces Plan to Present Results from Phase III Clinical Trial Evaluating ALTACE as Monotherapy and in Combination with Hydrochlorothiazide at the American Society of Hypertension Annual Meeting
10. Landmark Findings From ECLIPSE Program Show Improved Control of Perioperative Hypertension Reduces Risk of Death In Cardiac Surgery
11. BioSante Pharmaceuticals Announces New Findings for Potential Bird Flu Vaccine
Post Your Comments:
(Date:1/15/2014)... YORK , January 15, 2014 ... Ltd., the exclusive worldwide distributor of highly sophisticated agro-breeding ... on January 7, 2014, the Company,s board of directors ... Weiner as its new member of the board. ...
(Date:1/15/2014)... 15, 2014  In an unprecedented effort to curb the spread of ... other transport vehicles, an advanced and portable UV germicidal lamp manufactured ... first time. In order to prevent EMS paramedics ... West Palm Beach Fire Rescue is the ...
(Date:1/15/2014)... , Jan. 15, 2014 MultiCell Technologies, Inc. (OTC ... U.S. provisional patent application concerning composition of matter, biological ... targeted tumor cell death.  This patent ... double stranded RNA molecules (VSRNAs) which interfere with the ...
Breaking Medicine Technology:BreedIT (OTC: BRDT) Appoints Chemistry and Pharmaceutical Industry Expert Dr. Ben-Zion Weiner to Its Board of Directors 2BreedIT (OTC: BRDT) Appoints Chemistry and Pharmaceutical Industry Expert Dr. Ben-Zion Weiner to Its Board of Directors 3Superbugs No Longer Ride In Rescue Vehicles 2MultiCell Technologies Files Patent Application Covering New Class of RNA Therapeutics 2MultiCell Technologies Files Patent Application Covering New Class of RNA Therapeutics 3
... Pa., March 21, 2011 Core Essence Orthopaedics, Inc. ... announced today it has raised $11.5 million in Series ... by existing investor NewSpring Health Capital, Robin Hood Ventures ... $5 million Series A round, will support the commercialization ...
... Pa., March 21, 2011 Beginning April 1, Highmark ... of their insured patients with primary immunodeficiency diseases and ... single brand of immunoglobulin (IgG - a blood plasma ... new Highmark "formulary," even patients who are being treated ...
Cached Medicine Technology:Core Essence Secures $11.5 Million Series B Financing 2Core Essence Secures $11.5 Million Series B Financing 3Despite New Changes, Highmark Policy Still Threatens Patients With Primary Immunodeficiency Diseases 2Despite New Changes, Highmark Policy Still Threatens Patients With Primary Immunodeficiency Diseases 3
(Date:4/14/2014)... Popular web information on colorectal cancer is too difficult ... the appropriate risks to and concerns of patients, a ... In a review of a dozen popular websites, most ... screening were written beyond the recommended sixth-grade reading level, ...
(Date:4/14/2014)... study identifies a molecule that is a probable driving force ... an important target for colorectal cancer treatment and a valuable ... in two animal models and human tumors was published in ... researchers at The Ohio State University Comprehensive Cancer Center ...
(Date:4/14/2014)... more evidence that antibiotics can contribute to obesity. ... Antimicrobial Agents and Chemotherapy suggests that patients on ... in their gut microbiota. , The study, led ... 48 patients who were being treated long-term with doxycycline ...
(Date:4/14/2014)... who aren,t breastfed or not breastfed for long are ... health problems later in life, according to a new ... breastfeeding was important to influencing levels of inflammation in ... Institute for Advanced Research) Fellow in the Child & ...
(Date:4/14/2014)... beliefs about health that aren,t based on medical evidence are ... suggests. , In the Ohio State University study, a higher ... beliefs" on a standard measure of these thoughts was ... , Among the irrational beliefs assessed: Doubting the preventive ...
Breaking Medicine News(10 mins):Health News:Website information on colon cancer too complex, fails to address key concerns 2Health News:Website information on colon cancer too complex, fails to address key concerns 3Health News:Study identifies a likely key driver of colorectal cancer development and progression 2Health News:Long-term antibiotic treatment for Q fever causes weight gain 2Health News:Low birth weight, less breastfeeding create later health risks 2Health News:Irrational health beliefs linked to skipping cardiac rehab sessions 2Health News:Irrational health beliefs linked to skipping cardiac rehab sessions 3
... the liver, researchers say , FRIDAY, April 9 (HealthDay ... are at much higher risk of developing kidney cancer, ... 67,000 patients enrolled in the Henry Ford Health System ... hepatitis C developed kidney cancer. That,s double the rate ...
... ... ready for quick use by patients and personnel. , ... (PRWEB) April 9, 2010 -- The recent earthquakes ... large scale health emergencies. Healthcare organizations need products on hand to rapidly increase surge ...
... QuestNet Services (HK) Ltd, ... Social Service as a Caring Company for 2009/2010. The award is given to private companies operating ... Social Responsibility (CSR). , ... (PRWEB) April 9, 2010 -- QuestNet Services (HK) Ltd, for the third time in ...
... In light ... used and returned underwear, Pampered Passions Fine Lingerie has started a petition to champion stricter ... ... fine lingerie retailers, Pampered Passions Fine Lingerie , is speaking out against the recent ...
... ... of the 19th Annual Partnerships in Clinical Trials and located14th Annual eClinical Technology Summit, ... ... Data Management, a nonprofit association that supports data managers and others involved in clinical ...
... , ... Networks, a SC-based technology development company, unveiled it,s HyperSign product at the Digital Signage ... most innovative new digital signage solution. The software-as-a-service (SaaS) product simply and seamlessly ... or days like other similar products. , ...
Cached Medicine News:Health News:Provide Medical Surge Care with MasCache by DQE 2Health News:QuestNet is Recognised as a Caring Company for Three Consecutive Years 2Health News:QuestNet is Recognised as a Caring Company for Three Consecutive Years 3Health News:QuestNet is Recognised as a Caring Company for Three Consecutive Years 4Health News:Pampered Passions Fine Lingerie Starts Petition Against Retailers Selling Used Underwear and Lingerie 2Health News:SCDM to Showcase Professional Development Opportunities at Partnerships Event 2Health News:rAVe Publications Awards HyperSign "Most Innovative New Digital Signage Solution" 2
... Flexible Ureteroscope (DUR-D) incorporates many of ... durable, market leading DUR® series flexible ... device utilizing Gyrus ACMIs proprietary, worlds ... Oxide Semi-Conductor (CMOS) distal sensor technology ...
... new ImmunoCard STAT! EHEC is the first one-step ... Shiga Toxin 1 and 2 produced by Enterohemorrhagic ... on McConkey broth overnight enrichment of fecal specimens ... and 100% specificity., The separate result for Toxin ...
Inquire...
... elegant and sophisticated woman, the ... ophthalmic and sunwear styles. Frames ... of shapes and colors, designed ... and complexions. Many styles feature ...
Medicine Products: